HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Acetaminophen Dose Labeling, More Sunscreen Information Needed, House Appropriators Tell FDA

Executive Summary

Appropriators are "concerned that the lack of dosing information" on OTC drugs for children ages six months to 2 years "may lead to dosing errors, adverse events and inadequate treatment of fever and pain.” They also ask USDA about fraud in its National Organic Program.

Advertisement

Related Content

Proposed Sunscreen Rule, Final MUsT Guidance Jumpstart Next-Gen UV Filter Discussions
House Appropriators' Report Tracks With FDA Concern About CBD Supplements
E-cigarettes' Future Generates Questions, Not Their Efficacy For Smoking Cessation
Nicotine Poisoning Seizures Darken Cloud Around E-Cigarettes' NRT Potential
'Data Gaps' Keep 12 Ingredients Off FDA's Proposed OTC Sunscreen Monograph
Tylenol First To Move On Single Dosage For Children’s Acetaminophen
FDA Rule Stifles E-Cigarettes' Harm Reduction Role With Grandfather Date, Application Costs
Pediatric Acetaminophen Panel Debates Execution Of Dosing Changes

Topics

Advertisement
UsernamePublicRestriction

Register

RS148888

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel